As expected, GBA and PRKN variants were associated with lower AAO in our preliminary patient cohort,17, 18 whereas AAOs of patients with LRRK2 alterations were comparable to those without monogenic PD cause.19 This evidence concerns the gene GBA1 and Parkinson disease.